-
New Leadership in the New Congress
As the new Chair of Energy and Commerce's Oversight and Investigations subcommittee, it is now my responsibility to ensure that some of our most prominent federal agencies are working in the best interest of Americans. I will work tirelessly to ensure that they are working for us -- and that means taking real, meaningful steps to combat climate change and make health care more affordable for all Americans. --Diana DeGette -
Gun Violence Prevention
Americans are demanding that Congress pass sensible gun safety legislation. I'm continuing my ongoing work to make these reforms a reality, which will help keep all of our communities safer. -
Fulfilling DACA's Promise
President Trump's decision to rescind DACA is a crushing blow to more than 17,000 DREAMers in Colorado, but our fight isn't over. I will continue working to pass legislation, such as the Dream Act, that helps these young men and women remain in this country and achieve their American dream.
Home Page Tabs
Latest News
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) sponsored legislation filed today to ban the sale, manufacture or possession of any new military-style assault weapons.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) today released the following statement on the president’s decision to declare a national emergency:
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Scott Tipton (R-CO) introduced bipartisan legislation today to make permanent an existing national parks program that allows U.S. fourth-grade students, and their families, to visit any federally-managed parks, lands or waters for free for an entire year.
WASHINGTON, D.C. – Just days before the one-year anniversary of the tragic mass-shooting that took place at Marjory Stoneman Douglas High School in Parkland, Florida, a group of federal lawmakers is introducing legislation aimed at preventing another similar attack from occurring elsewhere in the U.S.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) and Sen. Edward J. Markey (D-Mass.) today called on the Food and Drug Administration (FDA) to provide documents related to its approval of Dsuvia, a new formulation of the opioid painkiller sufentanil.